Pathologic complete response rates of patients with ER-low/HER2-negative breast cancer treated with neoadjuvant pembrolizumab plus chemotherapy in the neo-real study - Bonadio, Renata Colombo; Tavares, Monique Celeste; Balint, Flavia Cavalcanti; Sousa, Isadora Martins de; Comini, Ana Carolina Marin; Madasi, Fernanda; Bines, Jose; Ferreira, Rafael Dal Ponte; Rosa, Daniela Dornelles; Hoff, Paulo Marcelo Gehm (Breast Cancer Research and Treatment, 2025)